ODI Pharma AB (publ) (NGM:ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.280
-0.120 (-5.00%)
At close: Jul 24, 2026

ODI Pharma AB Financials Overview

Millions SEK. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
29.823.1322.290.140.31-
Revenue Growth
182.05%-85.94%15880.34%-55.44%--
Gross Profit
8.620.844.62-0.72-0.1-
Operating Income
0.14-5.450.43-6.81-7.21-3.96
Net Income
-0.36-5.93-0.57-6.9-7.24-3.98
Earnings Per Share
-0.02-0.32-0.04-0.45-0.48-0.26
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
4.191.482.646.497.3614.62
Net Cash Growth
108.96%-43.87%-59.28%-11.76%-49.69%-28.71%
Net Cash Per Share
0.210.080.170.420.490.95
Cash & Investments
4.191.482.646.497.3614.62

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
2.4-3.31-3.82-5.1-7.37-6.06
Capital Expenditures
-----0-
Free Cash Flow
2.4-3.31-3.82-5.1-7.38-6.06
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
28.90%26.77%20.74%--33.12%-
Operating Margin
0.47%-173.94%1.92%-4884.20%-2302.98%-
Pretax Margin
-1.20%-189.19%-1.70%-4944.26%-2312.13%-
Profit Margin
-1.22%-189.33%-2.55%-4948.58%-2313.25%-
FCF Margin
8.05%-105.49%-17.16%-3659.83%-2357.80%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
1.4011.074.92600.26262.63-